Migraine Treatment Drugs Market Size

Migraine Drugs Market size was over USD 5.57 billion in 2023 and is projected to reach USD 23.2 billion by 2036, growing at around 11.6% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of migraine drugs is assessed at USD 6.09 billion.

The major key factors projected to drive the growth of the market include rise in the prevalence of migraines, stressed lifestyle along with rising healthcare expenditure. Since, numbers of migraine incidences are increasing and order to meet the unmet demand in migraine drugs, most of the companies are investing in research and development areas pertaining to migraine drugs. Further, novel product innovations and development of new devices for the new treatment options for migraine is anticipated to accelerate the growth of the market over the forecast period.